Home pharmaceuticals

pharmaceuticals

Stock Market Analysis & News

AstraZeneca shares slide 3.5%, analysts retain ‘Strong Buy’ rating

Galina Mikova

July 22, 2020

Stock Market Analysis & News

AstraZeneca Shares Gain Ground on Results from Covid-19 Vaccine Progress

Galina Mikova

July 21, 2020

WARNING: The content on this site should not be considered investment advice and we are not authorised to provide investment advice. Nothing on this website is an endorsement or recommendation of a particular trading strategy or investment decision. The information on this website is general in nature, so you must consider the information in light of your objectives, financial situation and needs. Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence or obtain advice where necessary. This website is free for you to use but we may receive a commission from the companies we feature on this site.

Buyshares.co.uk provides top quality insights through financial educational guides and video tutorials on how to buy shares and invest in stocks. We compare the top providers along with in-depth insights on their product offerings too. We do not advise or recommend any provider but are here to allow our reader to make informed decisions and proceed at their own responsibility. Contracts for Difference (“CFDs”) are leveraged products and carry a significant risk of loss to your capital. Please ensure you fully understand the risks and seek independent advice. By continuing to use this website you agree to our privacy policy.

Trading is risky and you might lose part, or all your capital invested. Information provided is for informational and educational purposes only and does not represent any type of financial advice and/or investment recommendation.

Crypto promotions on this site do not comply with the UK Financial Promotions Regime and is not intended for UK consumers.